Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Weighted Average)
Others
Ratios

Addex Therapeutics (ADXN) EBT: 2022-2024

Historic EBT for Addex Therapeutics (ADXN) over the last 3 years, with Dec 2024 value amounting to -$5.6 million.

  • Addex Therapeutics' EBT rose 44.61% to -$892,300 in Q2 2025 from the same period last year, while for Jun 2025 it was -$4.7 million, marking a year-over-year decrease of 9.28%. This contributed to the annual value of -$5.6 million for FY2024, which is 100.46% down from last year.
  • Per Addex Therapeutics' latest filing, its EBT stood at -$5.6 million for FY2024, which was down 100.46% from -$2.8 million recorded in FY2023.
  • In the past 5 years, Addex Therapeutics' EBT ranged from a high of -$2.8 million in FY2023 and a low of -$11.3 million during FY2022.
  • Moreover, its 3-year median value for EBT was -$5.6 million (2024), whereas its average is -$6.6 million.
  • As far as peak fluctuations go, Addex Therapeutics' EBT surged by 75.42% in 2023, and later tumbled by 100.46% in 2024.
  • Over the past 3 years, Addex Therapeutics' EBT (Yearly) stood at -$11.3 million in 2022, then soared by 75.42% to -$2.8 million in 2023, then plummeted by 100.46% to -$5.6 million in 2024.